The Latest Analyst Ratings for Alpine Immune Sciences
Portfolio Pulse from Benzinga Insights
Alpine Immune Sciences (NASDAQ:ALPN) received 10 analyst ratings in the last quarter, with an average price target of $21.6, representing significant upside from the current price of $12.4. The consensus shows 3 bullish, 7 somewhat bullish, and no bearish ratings. The average price target has increased by 25.22% from the previous target of $17.25.
November 15, 2023 | 5:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Alpine Immune Sciences has a positive outlook from analysts with an average price target of $21.6, suggesting a significant upside from the current price of $12.4.
The unanimous positive ratings from analysts, combined with a substantial increase in the average price target, suggest a strong bullish sentiment for ALPN in the short term. This could lead to increased investor confidence and a potential rise in the stock price.
CONFIDENCE 85
IMPORTANCE 90
RELEVANCE 100